Trishula Therapeutics
Rishi Sharma is a Sr. Clinical Trial Manager at Trishula Therapeutics, Inc. Rishi previously held roles at Axsome Therapeutics, Inc., Corcept Therapeutics, and Pharmacyclics. Rishi has a Bachelor's degree in Chemical Engineering from the University of California, Berkeley.
This person is not in any offices
Trishula Therapeutics
1 followers
Trishula Therapeutics is a clinical-stage cancer immunotherapy company developing TTX-030, a first-in-class anti-CD39 antibody.